Breast Cancer | Dr. Tony Talebi discusses treatment of Stage 4 "triple negative" breast cancer HD

Dr Tony Talebi interviews Dr Stefan Gluck regarding treatment of Stage IV triple negative breast cancer. Watch additional interviews on www.HemOnc101.com Breast cancer is the most common female cancer in the US, the second most common cause of cancer death in women, and the main cause of death in women ages 40 to 59. Important risk factors for breast cancer are age (older), gender (female), reproductive history (less children), hormonal factors (early menses and late menopause), and family history. Triple-negative breast cancer refers to any breast cancer that does not express the genes for estrogen receptor (ER), progesterone receptor (PR) or Her2/neu. Triple negative is sometimes used as a surrogate term for basal-like, however more detailed classification is possible providing better guidance for treatment and better estimates for prognosis. Standard treatment is surgery with adjuvant chemotherapy and radiotherapy. As a variation neoadjuvant (before surgery) chemotherapy is very frequently used for triple negative breast cancers. This allows for a higher rate of breast conserving surgeries and by evaluating the response to the chemotherapy gives important clues about the individual responsiveness of the particular cancer to chemotherapy. Here, Dr Stephan Gluck discuses general the treatment of metastatic stage 4 triple negative breast cancer. Dr. Stephan Gluck is currently a professor of medicine at the University of Miami Sylvester Comprehensive Cancer Center. Dr. Gluck Credentials: -Associate Division Chief for Clinical Affairs, Division of Hematology/Oncology -Clinical Director, Braman Family Breast Cancer Institute Education: University of Toronto Toronto, Canada Fellowship Bone Marrow Transplant and Medical Oncology 1991 Heinrich Heine University Dusseldorf, Germany Chief Resident Internal Medicine 1987 Heinrich Heine University Dusseldorf, Germany Residency Internal Medicine 1986 RWTH Aachen Aachen, Germany Ph.D. Experimental Pharmacology 1980 Free University of West Berlin Berlin, Germany M.D. Internal Medicine 1978 Free University of West Berlin Berlin, Germany Rotating Internship Internal Medicine 1978 Ruhr Universitaet Bochum, Germany Undergraduate Pre-Clinical Sciences 1974